Thursday, April 7th, 2016 - RnR Market Research

RnRMarketResearch.com adds Acute Pain Pipeline market research 2016 to its database, providing in-depth, high quality, transparent and market-driven, expert’s analysis.

Companies Profile discussed in this research:  A. Menarini Industrie Farmaceutiche Riunite Srl, AcelRx Pharmaceuticals, Inc., Adynxx, Inc., Amorsa Therapeutics Inc., AnaBios Corporation, Anavex Life Sciences Corp., AngioChem Inc., Antibe Therapeutics, Inc., AskAt Inc., Cara Therapeutics, Inc., Centrexion Corporation, Charleston Laboratories, Inc., ChironWells GmbH, Cytogel Pharma, LLC, Dompe Farmaceutici S.p.A. Grunenthal GmbH, Iroko Pharmaceuticals, LLC, KemPharm, Inc., Kineta, Inc., Laboratorios Del Dr. Esteve S.A., Mallinckrodt Plc, MEDRx Co., Ltd., Nanomerics Ltd, Nanotherapeutics, Inc., Nektar Therapeutics, Nuvo Research Inc., Orbis Biosciences, Inc., Orexo AB, Orion Oyj, Pacira Pharmaceuticals, Inc., Phosphagenics Limited, Recro Pharma, Inc., Shulov Innovative Science Ltd., Sigma-Tau S.p.A., Syntrix Biosystems, Inc., Thar Pharmaceuticals, Inc., Tonix Pharmaceuticals Holding Corp., Trevena, Inc. and Yungjin Pharm. Co., Ltd.

Inquire more about this research @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=522290

The report provides comprehensive information on the therapeutics under development for Acute Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acute Pain and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage..

Complete research across 202 pages

For DISCOUNT - http://www.rnrmarketresearch.com/contacts/discount?rname=522290

Scope

  • The report provides a snapshot of the global therapeutic landscape of Acute Pain
  • The report reviews pipeline therapeutics for Acute Pain by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved Acute Pain therapeutics and enlists all their major and minor projects
  • The report assesses Acute Pain therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news related to pipeline therapeutics for Acute Pain

Reasons to buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Acute Pain
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Acute Pain pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

File Library

Contact Profile

RnR Market Research


About Us:  

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us: 

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/feed


Ritesh Tiwari
P: + 1 888 391 5441
W: www.rnrmarketresearch.com/

Keywords

Acute Pain Therapeutic Products under Development, Key Players in Acute Pain Therapeutics, Acute Pain Pipeline Overview, Acute Pain Pipeline, Acute Pain Pipeline Assessment

Categories

Newsrooms

Sharing

More Formats